AAAAAA

   
Results: 1-13 |
Results: 13

Authors: ETOH T KATO J WASHIMINE H IMAMURA T KITAMURA K KOIWAYA Y KANGAWA K ETO T
Citation: T. Etoh et al., PLASMA PROADRENOMEDULLIN N-TERMINAL 20-PEPTIDE (PAMP) IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Hormone and Metabolic Research, 29(1), 1997, pp. 46-47

Authors: KUWASAKO K KITAMURA K ISHIYAMA Y WASHIMINE H KATO J KANGAWA K ETO T
Citation: K. Kuwasako et al., PURIFICATION AND CHARACTERIZATION OF PAMP-12 (PAMP[9-20]) IN PORCINE ADRENAL-MEDULLA AS A MAJOR ENDOGENOUS BIOLOGICALLY-ACTIVE PEPTIDE, FEBS letters, 414(1), 1997, pp. 105-110

Authors: INATSU H SAKATA J SHIMOKUBO T KITANI M NISHIZONO M WASHIMINE H KITAMURA K KANGAWA K MATSUO H ETO T
Citation: H. Inatsu et al., DISTRIBUTION AND CHARACTERIZATION OF RAT IMMUNOREACTIVE PROADRENOMEDULLIN N-TERMINAL 20 PEPTIDE (PAMP) AND THE AUGMENTED CARDIAC PAMP IN SPONTANEOUSLY HYPERTENSIVE RAT, Biochemistry and molecular biology international, 38(2), 1996, pp. 365-372

Authors: ETO T WASHIMINE H KATO J KITAMURA K YAMAMOTO Y
Citation: T. Eto et al., ADRENOMEDULLIN AND PROADRENOMEDULLIN N-TERMINAL-20 PEPTIDE IN IMPAIRED RENAL-FUNCTION, Kidney international, 1996, pp. 148-149

Authors: WASHIMINE H ISHIHARA T FUJIMOTO S KATO J KITAMURA K YAMAMOTO Y ETO T
Citation: H. Washimine et al., PLASMA-CONCENTRATION OF HUMAN ADRENOMEDULLIN (AM) AND PROADRENOMEDULLIN-N-TERMINAL-20-PEPTIDE (PAMP) IN PATIENTS WITH CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 653-653

Authors: WASHIMINE H ASADA Y KITAMURA K ICHIKI Y HARA S YAMAMOTO Y KANGAWA K SUMIYOSHI A ETO T
Citation: H. Washimine et al., IMMUNOHISTOCHEMICAL IDENTIFICATION OF ADRENOMEDULLIN IN HUMAN, RAT, AND PORCINE TISSUE, HISTOCHEM C, 103(4), 1995, pp. 251-254

Authors: WASHIMINE H YAMAMOTO Y KITAMURA K TANAKA M ICHIKI Y KANGAWA K MATSUO H ETO T
Citation: H. Washimine et al., PLASMA-CONCENTRATION OF HUMAN ADRENOMEDULLIN IN PATIENTS ON HEMODIALYSIS, Clinical nephrology, 44(6), 1995, pp. 389-393

Authors: KATO J KITAMURA K WASHIMINE H ETO T
Citation: J. Kato et al., PLASMA ADRENOMEDULLIN (AM) AND PROADRENOMEDULLIN-N-TERMINAL-20-PEPTIDE (PAMP) IN PATIENTS WITH PRIMARY ALDOSTERONISM (PA), Hypertension, 26(3), 1995, pp. 567-567

Authors: KATOH F KITAMURA K NIINA H YAMAMOTO R WASHIMINE H KANGAWA K YAMAMOTO Y KOBAYASHI H ETO T WADA A
Citation: F. Katoh et al., PROADRENOMEDULLIN N-TERMINAL 20-PEPTIDE (PAMP), AN ENDOGENOUS ANTICHOLINERGIC PEPTIDE - ITS EXOCYTOTIC SECRETION AND INHIBITION OF CATECHOLAMINE SECRETION IN ADRENAL-MEDULLA, Journal of neurochemistry, 64(1), 1995, pp. 459-461

Authors: WASHIMINE H KITAMURA K ICHIKI Y YAMAMOTO Y KANGAWA K MATSUO H ETO T
Citation: H. Washimine et al., PLASMA-CONCENTRATION OF HUMAN ADRENOMEDULLIN (AM) IN PATIENTS ON HEMODIALYSIS (HD), Journal of the American Society of Nephrology, 5(3), 1994, pp. 532-532

Authors: WASHIMINE H KITAMURA K YAMAMOTO Y ICHIKI Y KATOH F ISHIYAMA Y WADA A KANGAWA K MATSUO H ETO T
Citation: H. Washimine et al., IDENTIFICATION AND BIOLOGICAL-ACTIVITIES OF A NOVEL HYPOTENSIVE PEPTIDE, PROADRENOMEDULLIN N-TERMINAL 20 PEPTIDE (PAMP), Journal of the American Society of Nephrology, 5(3), 1994, pp. 596-596

Authors: KITAMURA K KANGAWA K ISHIYAMA Y WASHIMINE H ICHIKI Y KAWAMOTO M MINAMINO N MATSUO H ETO T
Citation: K. Kitamura et al., IDENTIFICATION AND HYPOTENSIVE ACTIVITY OF PROADRENOMEDULLIN N-TERMINAL-20 PEPTIDE (PAMP), FEBS letters, 351(1), 1994, pp. 35-37

Authors: WASHIMINE H KITAMURA K ICHIKI Y YAMAMOTO Y KANGAWA K MATSUO H ETO T
Citation: H. Washimine et al., IMMUNOREACTIVE PROADRENOMEDULLIN N-TERMINAL-20 PEPTIDE IN HUMAN TISSUE, PLASMA AND URINE, Biochemical and biophysical research communications, 202(2), 1994, pp. 1081-1087
Risultati: 1-13 |